MLTX 股價走勢圖
MLTX 股票價格預測
MoonLake Immunotherapeutics
$18.19
-1.51%
$-0.27
收盤價：May 22, 16:00:00 GMT-4
$18.1
-0.49%
$-0.08
盤後：May 22, 20:00:00 GMT-4
返回
MoonLake Immunotherapeutics (MLTX) 股票價格預測
關鍵數據
前收市價
$18.47
開盤價
$18.5
當日範圍
$18 - $18.75
52週區間
$5.95 - $62.75
交易量
653.5K
平均成交量
1.6M
股息收益率
--
每股盈餘 (TTM)
-3.52
市值
$1.2B
什麼是 MLTX？
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
